Journal article

Supraglottic airway devices for administration of surfactant to newborn infants with respiratory distress syndrome: a narrative review

Calum T Roberts, Brett James Manley, Joyce E O'Shea, Michael Stark, Chad Andersen, Peter G Davis, Adam Buckmaster

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | BMJ PUBLISHING GROUP | Published : 2021

Abstract

Surfactant is an effective treatment for respiratory distress syndrome, being particularly important for infants in whom continuous positive airway pressure (CPAP) provides insufficient support. Supraglottic airway devices present an attractive option for surfactant delivery, particularly as an alternative to methods dependent on direct laryngoscopy, a procedural skill that is both difficult to learn and in which to maintain competence. Published studies provide encouraging data that surfactant administration by supraglottic airway device can be performed with a high rate of success and may reduce the need for subsequent intubation compared with either continued CPAP or surfactant administra..

View full abstract